Trial intelligence / Profile preview

Pregabalin Monotherapy vs Pregabalin + Venlafaxine in Fibromyalgia

NCT07186751Recruiting

Sponsor
Beijing Tiantan Hospital
Start
Sep 2025
Primary completion
Jun 2027
Modality
Small Molecules
Countries
1
01

Overview

Trial of venlafaxine in fibromyalgia (FM) (2 arms), sponsored by Beijing Tiantan Hospital. Primary endpoint: Average pain intensity at 4 weeks. Started Sep 2025; status: recruiting.

02

Drugs

venlafaxine
03

Conditions

fibromyalgia (FM)

Beyond the preview

Go deeper on NCT07186751.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07186751.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call